Form 4: CytoDyn Inc. (WAFD), Mulholland Michael D., transaction 12/17/2020

Summary

A Form 4 filed with the Securities and Exchange Commission by Michael D. Mulholland, Chief Financial Officer of CytoDyn Inc., reporting option exercises and sales from 12/17/2020 to 12/21/2020. The reporting person exercised non-qualified stock options with exercise prices from $0.39 to $0.87 and sold the resulting shares: 32,000 on 12/17/2020 at a weighted average of $4.5523, 487,002 on 12/18/2020 at $4.9516 and 589,797 on 12/21/2020 at $5.582, returning the direct holding to 284,081 shares after each day. The explanation says the sales were made under a Rule 10b5-1 trading plan the reporting person entered into on November 12, 2020, providing for periodic sales by the reporting person's broker. The form, which prints the trading symbol as WAFD, is signed by Michael D. Mulholland and dated 12/21/2020.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Mulholland Michael D. (Last) (First) (Middle) 1111 MAIN STREET, SUITE 660 (Street) VANCOUVER WA 98660 (City) (State) (Zip) | Mulholland Michael D. | (Last) | (First) | (Middle) | 1111 MAIN STREET, SUITE 660 | VANCOUVER | WA | 98660 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ WAFD ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Financial Officer | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Financial Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 12/17/2020
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 12/17/2020 | M | 32,000 | A | $ 0.39 | 316,081 | D
Common Stock | 12/17/2020 | S (1) | 32,000 | D | $ 4.5523 (2) | 284,081 | D
Common Stock | 12/18/2020 | M | 155,500 | A | $ 0.39 | 439,581 | D
Common Stock | 12/18/2020 | M | 233,100 | A | $ 0.49 | 672,681 | D
Common Stock | 12/18/2020 | M | 98,402 | A | $ 0.57 | 771,083 | D
Common Stock | 12/18/2020 | S | 487,002 | D | $ 4.9516 (3) | 284,081 | D
Common Stock | 12/21/2020 | M | 201,598 | A | $ 0.57 | 485,679 | D
Common Stock | 12/21/2020 | M | 300,000 | A | $ 0.8 | 785,679 | D
Common Stock | 12/21/2020 | M | 88,199 | A | $ 0.87 | 873,878 | D
Common Stock | 12/21/2020 | S | 589,797 | D | $ 5.582 (4) | 284,081 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Non-qualified Stock Option (right to buy) | $ 0.39 | 12/17/2020 | M | 32,000 | 12/17/2020 (5) | 10/07/2029 | Common Stock | 32,000 | $ 0 | 155,500 | D
Non-qualified Stock Option (right to buy) | $ 0.39 | 12/18/2020 | M | 155,500 | 12/18/2020 | 10/07/2029 | Common Stock | 155,500 | $ 0 | 0 | D
Non-qualified Stock Option (right to buy) | $ 0.49 | 12/18/2020 | M | 233,100 | 12/18/2020 (6) | 06/08/2028 | Common Stock | 233,100 | $ 0 | 116,900 | D
Non-qualified Stock Option (right to buy) | $ 0.57 | 12/18/2020 | M | 98,402 | 12/18/2020 (7) | 06/01/2027 | Common Stock | 98,402 | $ 0 | 201,598 | D
Non-qualified Stock Option (right to buy) | $ 0.57 | 12/21/2020 | M | 201,598 | 12/21/2020 | 06/01/2027 | Common Stock | 201,598 | $ 0 | 0 | D
Non-qualified Stock Option (right to buy) | $ 0.8 | 12/21/2020 | M | 300,000 | 12/21/2020 (8) | 02/15/2023 | Common Stock | 300,000 | $ 0 | 0 | D
Non-qualified Stock Option (right to buy) | $ 0.87 | 12/21/2020 | M | 88,199 | 12/21/2020 (9) | 11/23/2025 | Common Stock | 88,199 | $ 0 | 161,801 | D
Explanation of Responses:
1. All shares sold and reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan the reporting person entered into on November 12, 2020. The plan provides for periodic sales by the reporting person's broker without further action by the reporting person.
2. This transaction was executed in multiple trades at prices ranging from $4.50 to $4.68. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and price at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $4.80 to $5.08. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
4. This transaction was executed in multiple trades at prices ranging from $5.03 to $6.00. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
5. The reported option became fully vested on October 7, 2020.
6. Sixty-seven percent (67%) of the reported option became fully vested on June 8, 2020; the shares remaining subject to this option vest on June 8, 2021.
7. The reported option became fully vested on June 1, 2020.
8. The reported option became fully vested on grant date.
9. Fifty percent (50%) of the reported option became fully vested in 2016 and 50% was forfeited.
Michael D. Mulholland | 12/21/2020
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_CYDY_4_filed2020-12-21_0001807094-20-000029.xml

Size

29,801 bytes

SHA-256

f2d5403f82661b86089da6d3985cef4d90b86741c38fcf5e94dd8117f79799c9

Our copy

SEC_CYDY_4_filed2020-12-21_0001807094-20-000029.xml

Original

www.sec.gov